14142 Federal Register / Vol. 80, No. 52 / Wednesday, March 18, 2015 / Notices 

treatment for more aggressive cancers 

versus non aggressive treatment. 

Competitive Advantages: The PCR 

based method is more advantageous and 

more objective than currently available 

histological classification and staging 

systems. 

Development Stage: 

• Early-stage. 

• In vitro data available. 

• In vivo data available (human). 

Inventors: Guiseppe Giaccone and 

Yisong Wang (NCI). 

Publication: Petrini I, et al. A specific 

missense mutation in GTF2I occurs at 

high frequency in thymic epithelial 

tumors. Nat Genet. 2014 Aug;46(8):844– 

9. [PMID 24974848]. 

Intellectual Property: HHS Reference 

No. E–109–2014/0—US Provisional 

Application No. 61/975,222 filed April 

4, 2014. 

Licensing Contact: Sabarni Chatterjee, 

Ph.D., MBA; 301–435–5587; 

chatterjeesa@mail.nih.gov. 

Collaborative Research Opportunity: 

For collaboration opportunities, please 

contact Dr. Guiseppe Giaccone at 

gg496@georgetown.edu. 

Systems and Devices for Training and 

Imaging an Awake Test Animal 

Description of Technology: The 

invention pertains to an apparatus and 

training system for rodents to maintain 

its head substantially motionless during 

an imaging procedure. The system 

includes a frame defining an enclosure 

for enclosing an animal therein during 

the imaging procedure which has a head 

post attached to the head of the animal 

and a treadmill having a plurality of 

rollers that the animal walks on such 

that one or more of the plurality of 

wheels rotate when the animal is in 

walking motion and stop rotating when 

the animal is in a substantially 

motionless state. This arrangement 

trains the animal to remain substantially 

motionless when disposed within an 

imaging apparatus. This invention 

permits prolonged imaging of awake 

rodents with minimal confinement and 

reduces stress. 

Potential Commercial Applications: 

• Imaging test rodents. 

• Imaging pharmacological agent 

distribution in rodents. 

• Imaging the therapeutically effects 

of pharmacological agent. 

Competitive Advantages: Imaging 

while animal is awake. 

Development Stage: 

• Early-stage. 

• Prototype. 

Inventors: Hanbing Lu, Yihong Yang, 

Elliot Stein (all of NIDA). 

Intellectual Property: HHS Reference 

No. E–043–2015/0—US Patent 

Application 14/589,725 filed January 5, 

2015. 

Licensing Contact: Michael 

Shmilovich; 301–435–5019; shmilovm@

mail.nih.gov. 

Collaborative Research Opportunity: 

The National Institute on Drug Abuse is 

seeking statements of capability or 

interest from parties interested in 

collaborative research to further develop 

apparatus and/or the training system; 

commercialize with pharmaceutical 

industry. For collaboration 

opportunities, please contact Vio 

Conley, M.S. at conleyv@mail.nih.gov. 

Miniature System for Manipulating 

Small Animals in High-Throughput 

Screening Small Molecules 

Description of Technology: The 

invention pertains to a miniaturized 

plating and feeding system based on a 

96-well microplate base and is intended 

to reduce manipulation of organisms as 

well as amounts of test drug/anesthetic, 

thereby mitigating waste. The kit 

comprises a feeder plate, transfer 

adaptor and receiver plate. The feeder 

plate is defined by, for example, a 

plastic 96-well plate with rounded 

wells. The rounded bottoms can 

dispense to or permit access to the test 

organism of liquid food or drug through 

about 7 holes of approximately 350 

microns in diameter. A top portion of 

the well provides test organisms (e.g., 

drosophila, daphnia) with sufficient 

space to enjoy normal life-cycles 

without confinement stress. The feeder 

plate includes means for interfacing 

with complementary components of the 

transfer and receiver plates through 

receiving holes and complementary 

dowels or pins. A transfer adapter 

allows the interconnection of the feeder 

plate to the receiver plate. The transfer 

plate can be configured to be square or 

rounded for the transfer of organisms 

from the feeder plate to the receiver 

plate. 

Potential Commercial Applications: 

• Drug Development. 

• Toxicity Studies. 

• Drug Design. 

Competitive Advantages: 

• Small animals. 

• High Throughput. 

• Space efficiency. 

• Resource economy. 

Development Stage: 

• Early stage. 

• Prototype. 

Inventors: Maria De Los Angeles Jaime 

and Brian Oliver (NIDDK). 

Intellectual Property: HHS Reference 

No. E–034–2015/0—US Provisional 

Application No. 62/080,181 filed 

November 14, 2014. 

Licensing Contact: Michael 

Shmilovich, Esq.; 301–435–5019; 

shmilovm@mail.nih.gov. 

Collaborative Research Opportunity: 

The National Institute of Diabetes and 

Digestive and Kidney Diseases is 

seeking statements of capability or 

interest from parties interested in 

collaborative research to further 

develop, evaluate or commercialize 

High-Throughput Small Animal 

Manipulation for Drug Design. For 

collaboration opportunities, please 

contact Marguerite J. Miller at 

millermarg@niddk.nih.gov. 

This abstract replaces one published 

on Thursday, January 29, 2015 (80 FR 

4935) to correct the patent application 

filing date. 

Dated: March 12, 2015. 

Richard U. Rodriguez, M.B.A., 

Acting Director, Office of Technology 

Transfer, National Institutes of Health. 

[FR Doc. 2015–06123 Filed 3–17–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Cancer Health Disparities/Diversity in Basic 

Cancer Research. 

Date: April 13–14, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Nywana Sizemore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6204, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1718, sizemoren@csr.nih.gov. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 52 / Wednesday, March 18, 2015 / Notices 14143 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: National Biomedical NMR Resource. 

Date: April 13–15, 2015. 

Time: 7:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Michael Eissenstat, Ph.D., 

Scientific Review Officer, BCMB IRG, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4166, 

Bethesda, MD 20892, 301–435–1722, 

eissenstatma@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and AIDS Related Research. 

Date: April 13, 2015. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Eduardo A Montalvo, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1168, montalve@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 12, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06121 Filed 3–17–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–14– 

085: Metabolic Reprogramming in 

Immunotherapy. 

Date: March 17, 2015. 

Time: 1:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Denise R Shaw, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7804, Bethesda, MD 20892, 301–435– 

0198, shawdeni@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 12, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06120 Filed 3–17–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–0020] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Coal Workers’ Health Surveillance 

Program (CWHSP)—(0920–0020)— 

Reinstatement with Change—National 

Institute for Occupational Safety and 

Health (NIOSH), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

NIOSH would like to submit an 

Information Collection Request (ICR) to 

revise the data collection instruments 

being utilized within the Coal Workers’ 

Health Surveillance Program (CWHSP). 

On May 1, 2014, the Mine Safety and 

Health Administration (MSHA) 

published final rule 30 CFR 70, 71, 72, 

75, and 90. The new MSHA rule added 

surface coal miners, a respiratory health 

assessment, and spirometry testing for 

chronic obstructive pulmonary disease 

(COPD) to the previously mandated 

chest x-ray examination program. These 

additions are being referred to as the 

Expanded CWHSP (an additional 

component under the current CWHSP). 

This request incorporates all 

components that now fall under the 

CWHSP. Those components include: 

Coal Workers’ X-ray Surveillance 

Program (CWXSP), B Reader Program, 

Enhanced Coal Workers’ Health 

Surveillance Program (ECWHSP), 

Expanded Coal Workers’ Health 

Surveillance Program, and National 

Coal Workers’ Autopsy Study (NCWAS). 

The CWHSP is a congressionallymandated medical examination program 

for monitoring the health of coal miners. 

The Program was originally authorized 

under the 1969 Federal Coal Mine 

Health and Safety Act and is currently 

authorized under the 1977 Federal Mine 

Safety and Health Act and its 

subsequent amendments (the Act). The 

Act provides the regulatory authority for 

mstockstill on DSK4VPTVN1PROD with NOTICES